Jandeleit-Dahm K, Burrell L M, Johnston C I, Koch K M
Department of Medicine, University of Hannover, Germany.
J Hypertens. 1997 Jun;15(6):643-50. doi: 10.1097/00004872-199715060-00011.
To measure the effect of hypertension on neointima formation after balloon injury of rat aorta and its association with the local angiotensin converting enzyme (ACE) concentration. Balloon angioplasty of the thoracic aorta using a 2 French Fogarty catheter was performed in spontaneously hypertensive rats (SHR) and normotensive Sprague-Dawley (SD) rats.
The injured aortic wall of SHR had already significantly higher ACE concentrations than did the uninjured aortic wall of normotensive SD rats (media: 729 +/- 37 dpm/mm2 in SHR versus 496 +/- 38 dpm/mm2 in SD rats, P < 0.01; intima: 83 +/- 5 dpm/mm2 versus 68 +/- 6 dpm/mm2 in SD rats, P < 0.01). Fourteen days after injury of the aorta the hypertensive rats had significantly higher neointima: media ratios than did the normotensive rats (0.83 +/- 0.09 versus 068 +/- 0.01, P < 0.01). This was associated with a significant increase in vascular media and neointima ACE concentrations in SHR (media 965 +/- 25 dpm/mm2, neointima 614 +/- 48 dpm/mm2) compared with those in normotensive SD rats after balloon angioplasty (media 669 +/- 23 dpm/mm2, neointima 287 +/- 33 dpm/mm2, P < 0.01). ACE inhibitor treatment with 10 mg/kg body weight lisinopril daily for 14 days by gavage reduced neointima proliferation in hypertensive and normotensive rats (neointima: media ratio: 0.35 +/- 0.02 for SHR, P < 0.01, versus untreated SHR with balloon injury; 0.28 +/- 0.01 for SD, P < 0.01, versus untreated SD rats with balloon injury). This was associated with significant vascular media ACE inhibition (SHR 149 +/- 9 dpm/mm2; SD rats 118 +/- 7 dpm/mm2; P < 0.01 versus untreated controls with balloon injury) and neointima ACE inhibition (SHR 73 +/- 4 dpm/mm2, SD rats 63 +/- 7 dpm/mm2, P < 0.01, versus untreated controls with balloon injury), but also lowered the blood pressure in SHR significantly (to 148 +/- 5 mmHg, P < 0.01, versus untreated SHR with balloon injury). When this drop in blood pressure was prevented by feeding the rats a high-salt diet (SHR with ACE inhibitor plus high salt-diet group blood pressure 193 +/- 3 mmHg, P = 0.57, versus untreated SHR) hypertension per se without the local ACE increase (ACE concentration in SHR with ACE inhibitor high-salt diet rats' media 167 +/- 10 dpm/mm2 and neointima 81 +/- 9 dpm/mm2) had only a mild effect on neointima formation after balloon angioplasty (neointima: media ratio 0.4 +/- 0.01 for SHR with ACE inhibitor plus high-salt diet versus 0.35 +/- 0.02 for SHR with ACE inhibitor plus normal-salt diet P < 0.05). Treatment with 10 mg/kg body weight angiotensin II subtype 1 receptor antagonist losartan potassium daily for 14 days by gavage was associated with a reduction in neointima formation similar to that observed with the ACE inhibitor both for SHR and for SD rats (neointima: media ratio 0.32 +/- 0.04 for SHR with losartan, 0.27 +/- 0.03 for SD rats with losartan; P < 0.01, versus untreated controls with balloon injury) suggesting that ACE inhibitor prevented neointima formation, at least in part by, reducing the local production of angiotensin II.
Neointima formation after balloon angioplasty in SHR is increased compared with that in normotensive SD rats. This is due mainly to there being a higher degree of activation of the renin-angiotensin system in the aorta of the SHR before and after balloon injury compared with that in normotensive SD rats measured in terms of the increased vascular ACE concentrations. Blood pressure alone had only a moderate effect on neointima formation.
测定高血压对大鼠主动脉球囊损伤后新生内膜形成的影响及其与局部血管紧张素转换酶(ACE)浓度的关系。采用2F Fogarty导管对自发性高血压大鼠(SHR)和正常血压的Sprague-Dawley(SD)大鼠进行胸主动脉球囊血管成形术。
SHR损伤的主动脉壁ACE浓度已经显著高于正常血压SD大鼠未损伤的主动脉壁(中膜:SHR为729±37 dpm/mm²,SD大鼠为496±38 dpm/mm²,P<0.01;内膜:SHR为83±5 dpm/mm²,SD大鼠为68±6 dpm/mm²,P<0.01)。主动脉损伤14天后,高血压大鼠的新生内膜与中膜比值显著高于正常血压大鼠(0.83±0.09对0.68±0.01,P<0.01)。与球囊血管成形术后的正常血压SD大鼠相比,SHR的血管中膜和新生内膜ACE浓度显著升高(中膜965±25 dpm/mm²,新生内膜614±48 dpm/mm²)(正常血压SD大鼠中膜669±23 dpm/mm²,新生内膜287±33 dpm/mm²,P<0.01)。每日经口给予10 mg/kg体重的赖诺普利进行ACE抑制剂治疗14天,可减少高血压和正常血压大鼠的新生内膜增殖(新生内膜与中膜比值:SHR为0.35±0.02,P<0.01,与球囊损伤未治疗的SHR相比;SD大鼠为0.28±0.01,P<0.01,与球囊损伤未治疗的SD大鼠相比)。这与血管中膜ACE显著受抑制有关(SHR为149±9 dpm/mm²;SD大鼠为118±7 dpm/mm²;与球囊损伤未治疗的对照组相比P<0.01)以及新生内膜ACE受抑制有关(SHR为73±4 dpm/mm²,SD大鼠为63±7 dpm/mm²,与球囊损伤未治疗的对照组相比P<0.01),但也使SHR的血压显著降低(降至148±5 mmHg,与球囊损伤未治疗的SHR相比P<0.01)。当通过给大鼠喂高盐饮食来防止这种血压下降时(ACE抑制剂加高盐饮食组SHR血压193±3 mmHg,与未治疗的SHR相比P = 0.57),高血压本身且无局部ACE升高(ACE抑制剂加高铁饮食的SHR大鼠中膜浓度167±10 dpm/mm²,新生内膜81±9 dpm/mm²)对球囊血管成形术后新生内膜形成仅有轻微影响(ACE抑制剂加高铁饮食的SHR新生内膜与中膜比值为0.4±0.01,与ACE抑制剂加正常盐饮食SHR的0.35±0.02相比P<0.05)。每日经口给予10 mg/kg体重的血管紧张素II 1型受体拮抗剂氯沙坦钾治疗14天,与ACE抑制剂类似,SHR和SD大鼠的新生内膜形成均减少(氯沙坦治疗的SHR新生内膜与中膜比值为0.32±0.04,氯沙坦治疗的SD大鼠为0.27±0.03;与球囊损伤未治疗的对照组相比P<0.01),提示ACE抑制剂至少部分通过减少局部血管紧张素II的产生来防止新生内膜形成。
与正常血压的SD大鼠相比,SHR球囊血管成形术后新生内膜形成增加。这主要是由于与正常血压SD大鼠相比,SHR球囊损伤前后主动脉中肾素-血管紧张素系统的激活程度更高,以血管ACE浓度增加来衡量。单纯血压对新生内膜形成仅有中等程度的影响。